About PathDrugomics


PathDrugomics exponentially increases the efficiency of drug discovery and disrupts the billion dollar per compound cost of bringing a new therapeutic into the market. Our products utilize the speed of accelerating computational technologies and the intelligence of big data analytics to model interactions between newly discovered drugs and their possible targets within diseases.



Our Founders


CEO

Todd Meyerrose, Ph.D.

Contact Todd

CTO

Justin Boyd, Ph.D

Contact Justin

COO

Morio Alexander, MBA

Contact Morio



© 2013 PathDrugomics
Site Design by RD&M